High Presalvage Radiation Therapy Prostate-Specific Antigen Strongly Correlates With Very Early Failure, Which Leads to Worse Outcome von Ying, J, Tumati, V, Yan, J, Xie, X.J, Roehrborn, C, Margulis, V, Pistenmaa, D.A, Hannan, R, Choe, K.S, Kim, D.W.N

Volltext

Extracranial Renal Cell Carcinoma Treated With Stereotactic Ablative Body Radiation Therapy Leads to Excellent Lesional Control von Wang, C.J, Huelsmann, L, Hannan, R, Timmerman, R.D, Meyer, J.J, Abdulrahman, R.E, Nedzi, L.A, Margulis, V, Brugarolas, J, Kim, D.W.N

Volltext

Early Results of a Phase I Pre-Operative Single Fraction Ablative Trial for Early Stage Breast Cancer von Rahimi, A.S., Leitch, M., Dogan, B., Alluri, P.G., Farr, D., Arbab, M., Seiler, S., Kim, D.W.N., Wooldridge, R., Unni, N., Nwachukwu, C.R., Patel, I., Zhang, Y., Parsons, D.D.M., Nguyen, A., Morgan, H.E., McArthur, H.L., Sahoo, S., Timmerman, R.D.

Volltext

Multi-Institutional Phase 2 Trial of High-Dose Stereotactic Body Radiation Therapy with Temporary Hydrogel Spacer for Low- and Intermediate-Risk Prostate Cancer von Folkert, M.R., Zelefsky, M.J., Hannan, R., Desai, N.B., Lotan, Y., Laine, A.M., Kim, D.W.N., Hardee, S., Hornberger, B., Kollmeier, M.A., McBride, S., Xie, X.J., Roehrborn, C., Timmerman, R.D.

Volltext